JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petty, W. C.
Right arrow Articles by Karler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petty, W. C.
Right arrow Articles by Karler, R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 150, Issue 3, 443-448, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


THE INFLUENCE OF AGING ON THE ACTIVITY OF ANTICONVULSANT DRUGS

W. Clayton Petty 1 and Ralph Karler 1

1 Department of Pharmacology, University of Utah College of Medicine, Salt Lake City, Utah

The influence of aging on the activity of five anticonvulsant agents was studied in rats and mice. In addition, the relation of aging to the CO2 content of the cerebral cortex of the rat was investigated.

In the rat, the ED50 values in four of the five agents studied decreased with age. Three of the drugs whose ED50 values fell with age are considered to act through the same mechanism, an increase in the CO2 content of the central nervous system. These anticonvulsants are C02, acetazolamide, and sulfanilamide. The increase in sensitivity of the nervous syste to CO2 was not related to detectable changes in the amount of CO2 in the cerebral cortex. In addition, changes in the amount of CO2 could not be measured in the cortex after administration of anticonvulsant doses of acetazolamide. The marked sensitivity of the central nervous system to CO2 in old rats indicates that changes in tissue CO2 below the limits of manometric detection are sufficient to produce anticonvulsant effects.

At present it is not possible to relate any changes in blood-brain barrier, in rates of drug metabolism, in the level of central nervous system excitability, or in carbonic anhydrase activity to the decrease in ED50 observed for acetazolamide and sulfanilamide. It appears that the decrease in ED50 of these agents is the consequence of an increase in sensitivity of the nervous system to CO2. The ED50 for phenobarbital also decreased with age, and this decrease may be the consequence of a decrease in the rate of metabolism of the barbiturates with age.

The mice data demonstrate some species differences from the rat. The ED50 for both acetazolamide and diphenylhydantoin increased with age. Mice, nevertheless, resemble rats in that the ED50 for CO2 decreased with age. Therefore, in both species aging is associated with an increase in sensitivity of the nervous system to the anticonvulsant effects of CO2.

Accepted on June 30, 1965




This article has been cited by other articles:


Home page
ScienceHome page
D. Gallager and P Mallorga
Diphenylhydantoin: pre- and postnatal administration alters diazepam binding in developing rat cerebral cortex
Science, April 4, 1980; 208(4439): 64 - 66.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.